
Pfizer to sell consumer healthcare businesses to J&J
Pfizer to sell consumer healthcare businesses to J&J
Pfizer to sell consumer healthcare businesses to J&J
Pfizer Inc. has reached an agreement to sell its Pfizer Consumer Healthcare business to Johnson & Johnson for $16.6 billion in cash. Pfizer's worldwide market-leading brands include Listerine oral care products, Nicorette smoking cessation treatments, Lubriderm, Visine, Neosporin, Sudafed, Zantac, and Benadryl. J&J will also acquire the OTC switch rights to Zyrtec (Pfizer's once-a-day, nonsedating prescription antihistamine) upon patent expiration.
To see more Hot off the Press news articles, click here
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


























































































































































